Community Resources Temple University
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2020 List of Hospital Electronic Medical Records (EMR) Connected to Outpatient Dialysis Clinics in the Network 4 Service Area
2020 List of Hospital Electronic Medical Records (EMR) Connected to Outpatient Dialysis Clinics in the Network 4 Service Area A Abington Jefferson Health: Abington-Lansdale and Abington Hospitals. Other network hospitals may be connected. Albert Einstein Medical Center Alleghany Health Network: Alleghany General, Jefferson, St. Vincent and West Penn Hospitals. Other network hospitals may be connected Aria-Jefferson Health: Jefferson Torresdale Hospital Armstrong County Memorial Hospital B Bayhealth: Kent General Hospital (Delaware) Butler Health System: Butler Memorial Hospital C Chestnut Hill Hospital Children's Hospital of Philadelphia Christiana Hospital (Delaware) Commonwealth Health System: Wilkes Barre General Conemaugh Health System: Conemaugh Memorial Medical Center Crozer Chester Medical Center D -E-F-G Doylestown Health: Doylestown Hospital Ephrata Excela Health: Latrobe and Westmoreland Hospitals. Other network hospitals may be connected. Geisinger: Danville, Geisinger Community Medical Center, Holy Spirit, Lewistown and Wyoming Valley Hospitals Grandview Hospital Guthrie Towanda Memorial Hospital H-I-J Heritage Valley Health System: Beaver and Sewickley Hospitals Holy Redeemer Hospital Indiana Regional Medical Center Jennersville Regional Hospital L-M-N-O Lancaster General Health: Lancaster General Hospital Lankenau Medical Center Revised 3/11/20 Page 1 2020 List of Hospital Electronic Medical Records (EMR) Connected to Outpatient Dialysis Clinics in the Network 4 Service Area Lehigh Valley Health Network: Bethlehem, Hazleton, Lehigh Valley and Pocono Hospitals. Other network hospitals may be connected. Main Line Health: Riddle Memorial Hospital Memorial Medical Center Mercy Catholic Medical Center: Mercy Fitzgerald Hospital P Penn Highlands Healthcare: Brookville, Clearfield and Dubois Penn Medicine: Pennsylvania Hospital Penn State Health: St. Joseph's Medical Center Phoenixville Hospital Pottstown Hospital Punxsutawney Area Hospital Q-R-S Reading Hospital Sharon Regional Medical Center St. -
Springer A++ Viewer
PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central Ubiquitin researchers win Nobel ArticleInfo ArticleID : 5007 ArticleDOI : 10.1186/gb-spotlight-20041007-02 ArticleCitationID : spotlight-20041007-02 ArticleSequenceNumber : 70 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 3 RegistrationDate : 2004–10–7 ArticleHistory : OnlineDate : 2004–10–7 ArticleCopyright : BioMed Central Ltd2004 ArticleGrants : ArticleContext : 130595511 Stephen Pincock Email: [email protected] Three researchers who made fundamental breakthroughs in understanding ubiquitin-mediated proteolysis have been awarded the 2004 Nobel Prize in Chemistry, the Royal Swedish Academy of Sciences said on Wednesday (October 6). Aaron Ciechanover and Avram Hershko, from the Israel Institute of Technology, Haifa, and Irwin Rose, of the University of California, Irvine, will share the prize for their discoveries in the 1970s and 1980s that began to reveal the central role of the tiny 76-amino acid protein in numerous cellular processes. "Thanks to the work of the three laureates, it is now possible to understand at a molecular level how the cell controls a number of central processes by breaking down certain proteins and not others," the academy said. "Without doubt they deserve this prize," John Mayer, professor of molecular cell biology at the University of Nottingham, told us. "Protein modification by ubiquitylation is just as important as protein phosphorylation for what goes on in the cell." Ubiquitin-mediated protein degradation governs processes as varied as cell division, DNA repair, quality control of newly produced proteins, and parts of the immune system. Problems with the ubiquitin–proteosome system are implicated in human diseases including cervical cancer and cystic fibrosis. "The reason they've got this Nobel Prize is because ubiquitin is attached to proteins in different ways not only for degradation, but also to make other things happen in the cell," Mayer added. -
Ubiquitin-Mediated Proteolysis the Nobel Prize in Chemistry for 2004 Is
Advanced information on the Nobel Prize in Chemistry, 6 October 2004 Information Department, P.O. Box 50005, SE-104 05 Stockholm, Sweden Phone: +46 8 673 95 00, Fax: +46 8 15 56 70, E-mail: [email protected], Website: www.kva.se Ubiquitin-mediated proteolysis The Nobel Prize in Chemistry for 2004 is shared between three scientists who have made fundamental discoveries concerning how cells regulate the breakdown of intracellular proteins with extreme specificity as to target, time and space. Aaron Ciechanover, Avram Hershko and Irwin Rose together discovered ubiquitin- mediated proteolysis, a process where an enzyme system tags unwanted proteins with many molecules of the 76-amino acid residue protein ubiquitin. The tagged proteins are then transported to the proteasome, a large multisubunit protease complex, where they are degraded. Numerous cellular processes regulated by ubiquitin-mediated proteolysis include the cell cycle, DNA repair and transcription, protein quality control and the immune response. Defects in this proteolysis have a causal role in many human diseases, including a variety of cancers. Fig. 1 Ubiquitin-mediated proteolysis and its many biological functions 2 Introduction Eukaryotic cells, from yeast to human, contain some 6000 to 30000 protein-encoding genes and at least as many proteins. While much attention and research had been devoted to how proteins are synthesized, the reverse process, i.e. how proteins are degraded, long received little attention. A pioneer in this field was Schoenheimer, who in 1942 published results from isotope tracer techniques indicating that proteins in animals are continuously synthesized and degraded and therefore are in a dynamic state (Schoenheimer, 1942). -
Temple Health Magazine
LEWIS KATZ SCHOOL OF MEDICINE AT TEMPLE UNIVERSITY | TEMPLE UNIVERSITY HEALTH SYSTEM WINTER 2021 CONQUERING THE CLOT Tackling Thrombosis with Technology and Tenacity COVID-19 AT TEMPLE: STORIES UNMASKED SEPSIS: INSIGHTS, INNOVATIONS AGENDA Temple Health Magazine EDITOR Giselle Zayon [email protected] Health Magazine DESIGN & ART DIRECTION B&G Design Studios WRITERS & CONTRIBUTORS TKarenemple Brooks HealthMagazine Christopher Guadagnino Meredith Mann Jennifer Reardon Andrew Smith Jeremy Walter BUSINESS MANAGER Younndia Rush ADMINISTRATION Christopher Guadagnino, PhD Director, Communications Anne Carlin Practical Wisdom Director, Alumni Relations CONTACT US n the spring of 2020, when the City of Philadelphia needed a large indoor Office of Communications space to convert to a field hospital during the COVID-19 pandemic, any 3509 N. Broad Street Philadelphia, PA 19140 number of complexes in town could have sufficed — but Temple was the 215-707-4839 only organization to answer that call, lending the City its 340,000- square-foot Liacouras Center (page 18). TempleHealth.org IIn 2017, a Temple physician named Riyaz Bashir, MD, was frustrated. Not a 1-800-TEMPLEMED single catheter on the market could do what he needed a catheter to do, so he Lewis Katz School of Medicine Temple University Hospital designed one himself. Now the unique tool — designed to instantly restore blood Temple University Hospital flow through blood clots — is poised for worldwide use (pages 12 and 44). There’s Episcopal Campus Temple University Hospital been lots of practical Temple thinking about blood clots: the namesake of the Jeanes Campus Temple University Hospital university’s Thrombosis Research Center — Sol Sherry, MD (1916-1993) — Northeastern Campus basically invented the field of using enzymes to melt clots (pages 12 and 46). -
Temple University Health System Table of Contents
Temple University Health System Table of Contents 1. Temple University Hospital Community Commitment 2. Programs to Promote Access to Care and Improve Community Health 3. Community Health Needs Assessment Summary 4. Plan to Improve Health of Moms and Newborns 5. Plan to Address Obesity and Overweight BMI 6. Plan to Improve Heart and Vascular Health 7. Plan to improve Access to Mental Health Resources 8. Plan to Strengthen Awareness of Gun Violence 9. Plan to Strengthen Practices for Culturally Competent Care 10.Approach to Unmet Needs 11.Looking Forward to a Healthier Population Temple University Hospital Community Commitment Temple University Hospital was founded in 1892 as “Samaritan Hospital,” with the mission of caring for patients with limited incomes and ensuring access to medical care in its surrounding neighborhoods. Today, Temple University Hospital is a 714-bed non-profit acute care hospital that provides a comprehensive range of medical services to its North Philadelphia neighborhoods, as well as a broad spectrum of secondary, tertiary, and quaternary care to patients throughout Southeastern Pennsylvania. Temple University Hospital serves one of our nation’s most economically challenged and diverse urban populations. About 84% of the patients served by Temple University Hospital are covered by government programs, including 31% by Medicare and 53% by Medicaid. We are an indispensable provider of health care in the largest city in America without a public hospital. Among Pennsylvania’s full-service safety-net providers, Temple University Hospital serves the greatest volume and highest percentage of patients covered by Medicaid. Temple University Hospital also serves as a critical access point for vital public health services. -
Community Resources 2019
A GUIDE TO Community Resources 2019 Peek inside ARTS AND CULTURE ..... 4 CAREER .............................7 EDUCATION .....................10 HEALTHCARE ................. 13 TEMPLE UNIVERSITY COMMUNITY RELATIONS Table of Contents 20/20 Scholarship Program Community Connections Media Arts ...........................................11 Each year, Temple University awards Adult Education ...........................11–12 up to 25 scholarships to ambitious, Welcome .............................................. 2 college-bound students from ZIP Community Relations ...................... 3 Healthcare codes 19121, 19122, 19132 and 19133 Outreach Programs .......................... 3 in North Philadelphia. Location Information.......................13 Arts and Culture Family Practice .................................13 SFS.TEMPLE.EDU Women and Infants .........................13 Temple Libraries ................................ 4 Oral Health .........................................14 Community Arts ................................ 4 Foot Care ............................................14 Performing Arts ............................ 4–5 Heart Health ......................................15 Athletics Additional Services .........................15 Events................................................... 6 Legal Services Facilities .............................................. 6 Legal Aid .............................................16 Career Tax Preparation .................................16 Workforce Job Training .........................................7 -
HMO Proactive Tiered Network Hospital List
Save with Keystone HMO Proactive, our most popular plans Keystone HMO Proactive health plans are our most popular for good reason: You get access to high-quality care and save money. Not only do you pay less for your monthly premiums, but you can save even more by choosing doctors and hospitals in Tier 1 – Preferred. Save with Tier 1 – Preferred Tier 1 – Preferred includes more than 50 percent of the network. Keystone HMO Proactive offers the same essential health benefits as our other health plans, including doctor visits, Tier 1 – Preferred hospital stays, prescription drug coverage, blood tests, and X-rays. The difference is its tiered provider network, which gives you the option to pay less for care by choosing Tier 1 –Preferred providers. Here are the most important things to know about Keystone HMO Proactive: • You can visit any doctor or hospital in the Independence Blue Cross network once you have a referral. Tier 2 – Enhanced Tier 3 – Standard • You will select a PCP to coordinate your care and refer you to specialists. • Some services cost the same no matter what provider you Save even more choose — like preventive care, emergency room visits, and Keystone HMO Silver Proactive Select and Keystone HMO Silver urgent care. Proactive Value: These lower-premium options are only available • When you use doctors and hospitals in Tier 1 – Preferred, when you purchase directly from Independence Blue Cross. you pay the lowest out-of-pocket costs. Keystone HMO Silver Proactive Value includes a deductible for • The choice is always yours. You can choose Tier 1 providers Tiers 1 – 3 for some services. -
Futuristic Operating Rooms Open At
RELEASE DATE | JUNE 2013 For all faculty, physicians, students and staff of Temple’s healthcare enterprise. World Class: Futuristic Operating Not an Exaggeration I’m very proud to announce that Temple Health Rooms Open at TUH now offers the most advanced robotic operating suite in the world – one of the latest examples of Hybrid ORs and 3-D Robotic ORs Enhance Care how we are translating our growth strategies into results that will solidify the long-term success of Recently, the hospital debuted the world’s most The new ORs will accommodate multiple our thriving healthcare enterprise. (See article on advanced 3-D Robotic OR Suite and the first of surgical specialties including cardiac, urology, this page.) two “Hybrid” Operating Rooms. gynecology, thoracic, otolaryngology, transplant Temple University Hospital’s new twin robotic ORs and hepatobiliary, and general surgery. The new Setting a New Standard in Robotics feature the latest dual-console da Vinci SI Surgical robotic operating rooms also have the capability Systems and an observation area equipped with to feed live video to remote locations, including Temple’s new twin robotic operating rooms 3-D viewing capability – something not currently sites within the School of Medicine and a state- available anywhere else. Temple’s 3-D capability allow two robotic surgeries to be performed of-the-art conference room down the hall simultaneously by surgeons at separate for external observers enhances medical education from the ORs. and permits greater flexibility among all members consoles inside the shared observation/control of the surgical team, offering unparalleled room. There are 3-D monitors throughout the “The twin robotic operating rooms were designed specifically with patient safety and visualization of surgical procedures. -
Rfa 01-07-07 - Grants for Resources Awards by County
RFA 01-07-07 - GRANTS FOR RESOURCES AWARDS BY COUNTY County Lead Organization Site Name Award Amt Adams 5 TOTAL SERVICE DELIVERY SITE(S) Keystone Rural Health Center Keystone - Farmworkers Program, Adams $89,390.52 Co. WellSpan Medical Group Adams Co. Women's Health $52,144.47 Biglerville F.M. $67,042.89 Fairfield Med. Ctr. $67,042.89 Herr's Ridge F.M. $74,492.10 Adams County Subtotal $350,112.87 Allegheny 25 TOTAL SERVICE DELIVERY SITE(S) Children's Hospital of Pittsburgh of the CHP at Braddock $89,390.52 UPMC Health System CHP at Wilkinsburg $96,839.73 Duquesne University of the Holy Ghost K. Leroy Irvis - Mgd Wellness Center $52,144.47 St. Justin Plaza - Mgd Wellness Center $52,144.47 East Liberty Family Health Care Center, East Liberty Office $74,492.10 Inc. Lincoln-Lemington Office $74,492.10 Magee-Womens Hospital of UPMC Magee at Clairton $89,390.52 Health System Magee at Wilkinsburg $89,390.52 North Side Christian Health Center North Side Christian Health Center $81,941.31 Primary Care Health Services, Inc. Alma Illery Medical Center $100,000.00 Braddock Medical Center $89,390.52 Center City Health Center $89,390.52 Monday, June 24, 2002 Grants for Resources Page 1 of 14 RFA 01-07-07 - GRANTS FOR RESOURCES AWARDS BY COUNTY County Lead Organization Site Name Award Amt Primary Care Health Services, Inc. Duqesne Medical Center $89,390.52 Hazelwood Medical Center $89,390.52 Manchester Health Center $89,390.52 McKeesport Family Health Center $89,390.52 Rankin Family Health Center $89,390.52 Steel Valley Health Center $89,390.52 West End Health Center $81,941.31 Westinghouse School Based Health Center $81,941.31 Wilkensburg Health Center $89,390.52 Shadyside Hospital Foundation East End CHC $81,941.31 Sto-Rox Neighborhood Health Council, Sto-Rox Family Health Center $89,390.52 Inc. -
Proteasome Inhibitors in Cancer Therapy: Death by Indigestion
Cell Death and Differentiation (2005) 12, 1255–1257 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Book Review Proteasome inhibitors in cancer therapy: death by indigestion M Rossi1, A Oberst2, A Emre Sayan1 and P Salomoni*,1 1 MRC, Toxicology Unit, Leicester, UK; 2 IDI-IRCCS Biochemistry Lab, c/o University of Rome Tor Vergata, Rome, Italy * Corresponding author. P Salomoni. E-mail: [email protected] Cell Death and Differentiation (2005) 12, 1255–1257. doi:10.1038/sj.cdd.4401701 Proteasome Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development. By J Adams. Humana Press, Totowa, New Jersey: 2004. pp 312. ISBN: 1-58829-250-9 As Eugene Garfield said, while it is easy to recognize a good same issue containing manuscripts from scientists that have paper, it could be more difficult to recognize a bad paper. In originated in this field.7–10 fact, the results could be weak, but the conclusion could still For those of us engaged in basic research in the field be right, even though not fully supported by the data shown. of cancer and apoptosis, the hope that our work might, in Preliminary reports could also fall in this category. After some small way and at some future juncture, contribute to all, it was not a Cell but a BBRC paper – only a little BBRC of the clinical treatment of human cancers is a major motivator. three impact factor – describing a novel experimental model Proteasome Inhibitors in Cancer Therapy, edited by Julian in which to study ATP-dependent proteolysis.1 In a lysate Adams, which is part of the ‘Cancer Drug Discovery and from rabbit reticulocytes, where the proteolytic activity was not Development’ series from Humana Press, tells the happy tale due to lysosomes (pH optimum of 7.8), they separated two of one drug’s journey from concept, through development, fractions in a DEAE cellulose column, each one individually to FDA approval, and application. -
Shusterman Hall
Main Campus TEMPLE UNIVERSIT Y Buildings and Departments SUSQUEHANNA AVENUE 4;.9*44&1.7?%,17747/<:26.:: T 6-.9:76*44 STREE STREET E S 66.6+.90*44 AVENUE 65 IN 32 RV ;4*6;2,&.9526*4 15th STREET 13th STREET 12th STREET 11th STREET 16 PARK BROAD STREET WATT LOT 892=*;.4@-.=.478.-17<:260 5 MA =.6<.!79;17584.? &1.-0.892=*;.4@-.=.478.- DIAMOND STREET DIAMOND STREET :;<-.6;17<:260 23 %178: 30 3 15 60 LOT *8;2:;&.584. 25 10 57 *99*,3*44 38 42 36 *9;76*44#1@:2,*4%,2.6,. CARLISLE STREET NORRIS STREET sand NORRIS STREET *9;76 volleyball *9;76 33 9 18 58 8B .<9@*44 48 44A 10 LOT 7 27470@2/.%,2.6,.:<24-260 54 tennis courts *58<:#742,.%<+%;*;276 31 44B 8A 50 11 22 POLETT WALK *58<:%*/.;@%.9=2,.: BERKS STREET 6 LOT 1 52 BELL TOWER *96.44*44 21 7 2 45 35 20 76>.44*44) 48 29 62 47 26 76>.447<:. 59 55 13 17 LIACOURAS WALK 16th STREET 15th STREET 13th STREET 12th STREET 11th STREET 10th STREET 37 BELL BROAD STREET 1 VISITORS 12 4 GARAGE -+.90"4:7677;+*44 14 PARKING WARNOCK STREET #9*,;2,.*,242;@ MONTGOMERY AVENUE MONTGOMERY AVENUE R 2*,7<9*:)*43 27 :;<-.6;:.9=2,.: 49A 28 28A 40 6026..9260*6-9,12;.,;<9. 63 6;.9;*265.6;*6-755<62;@ 41 49B VISITORS PARKING VISITORS LIACOURAS CENTE LIACOURAS 64 -<,*;276.6;.9*6-9.;*24:178: 28B 43 51A 39 LOT 9 )$& 19 61 CECIL B. -
Steven J. Cohen, Md
STEVEN J. COHEN, MD Background Oncology Cornell University Director, Rosenfeld Cancer Center and Cancer Service Line Ithaca, NY Chief, Medical Oncology and Hematology Division (BA, Psychology, 1988-1992) Vice-Chair, Department of Medical Oncology Professor of Medical Oncology, Thomas Jefferson University, Stony Brook University School of Medicine Sidney Kimmel Cancer Center Stony Brook, NY (MD, 1992-1996) Steven J. Cohen, MD earned his Bachelor’s degree in Psychology Temple University Hospital in 1992 from Cornell Philadelphia, PA University. In 1996, he earned (Resident, Internal Medicine, 1996-1999) his medical degree from the State University of New York at Fox Chase Cancer Center Stony Brook. Dr. Cohen Temple University Hospital completed his residency in Philadelphia, PA Internal Medicine at Temple (Fellow, Medical Oncology and Hematology, 1999-2001) University Hospital in 1999. He (Chief Fellow, Medical Oncology and Hematology, 2001- completed his fellowship in 2002) Medical Oncology and (Program Director, Hematology/Oncology Fellowship, Hematology in 2002 at Fox 2009-2016) Chase Cancer Center, and also served as Chief Fellow from 2001 to 2002. Fox Chase Cancer Center Philadelphia, PA Dr. Cohen specializes in the care and treatment of GI cancers. He is a member of the American Society of Clinical (Assistant Member, Division of Medical Science, 2002- Oncology, where he has served on the Scientific Program 2004) Committee for Colorectal Cancer and chaired the Test (Attending Physician, Department of Medical Oncology, Development Committee. He is an active member of the GI 2002-2004) Committee of the Eastern Cooperative Oncology Group (Assistant Professor, Divisions of Medical and Population where he has chaired the Colorectal Cancer Subcommittee.